As efforts such as The Cancer Genome Atlas and others generate vast quantities of information about the genetic makeup of different types of cancer, it is becoming increasingly clear that such information has great potential for determining which anticancer drugs should be used to treat a specific patient. However, realizing that potential will require not only that cancer researchers uncover …

This entry was posted on Saturday, February 20th, 2010 at 9:12 am and is filed under Nano Medicine. You can follow any responses to this entry through the RSS 2.0 feed. You can skip to the end and leave a response. Pinging is currently not allowed.

---